BPC-157
Body Protection Compound-157 · Pentadecapeptide BPC 157
A synthetic pentadecapeptide fragment derived from a protective protein found in human gastric juice, studied extensively in animal models for tissue-repair and gastrointestinal-protective mechanisms.
Research use only. This profile documents BPC-157 strictly as a laboratory research compound based on published animal and in-vitro literature. It is not medical advice, not a human dosing guide, and does not claim safety for human or animal consumption outside a controlled research setting.
BPC-157 takes its name from "Body Protection Compound," reflecting its origin as a stable fragment isolated from a larger protective protein found in human gastric juice. Unlike many research peptides that are close analogs of known hormones, BPC-157 is notable in the literature for having a body of animal-model research spanning gastrointestinal protection, tendon and ligament healing, and broader tissue-repair mechanisms — making it one of the most cross-referenced compounds in the recovery-peptide research space.
Mechanism of action
The mechanistic literature on BPC-157 centers on angiogenesis — the formation of new blood vessels — and its apparent modulation of several growth-factor pathways relevant to tissue repair. Animal studies have reported effects on vascular endothelial growth factor (VEGF) receptor expression and on the nitric oxide signaling system, both of which are implicated in wound-healing cascades. Additional research has examined BPC-157's interaction with the growth hormone receptor pathway, particularly in models of tendon-to-bone healing, where impaired vascularization is a known limiting factor in recovery.
A distinguishing feature frequently noted in the literature is BPC-157's apparent stability in gastric environments, consistent with its origin as a fragment of a gastric-protective protein. This has made it a recurring subject in gut-brain axis and gastrointestinal ulcer research models, distinct from the musculoskeletal-repair literature it's also known for.
What the research literature reports
Published animal-model studies on BPC-157 report effects across several tissue-repair contexts: accelerated healing in models of tendon transection, improved outcomes in models of muscle injury, and gastroprotective effects in models of NSAID-induced gastric ulceration. A recurring theme across this literature is BPC-157's reported activity across multiple tissue types — skin, muscle, tendon, ligament, and gut mucosa — which researchers have used to argue for a broadly acting repair-signaling mechanism rather than a tissue-specific one.
It's important to note that the great majority of published BPC-157 research to date has been conducted in animal models (primarily rodent) rather than in large controlled human trials, which is a common caveat researchers attach when discussing translational relevance. This is one of the reasons BPC-157 remains classified and sold specifically as a research chemical rather than an approved therapeutic.
The angiogenesis literature is where most of BPC-157's proposed cross-tissue repair mechanism converges.
Relationship to TB-500
BPC-157 is frequently studied and sold alongside TB-500 (see our TB-500 compound profile), another tissue-repair-focused research peptide with a distinct mechanism centered on actin regulation. Several suppliers, including NextGenPeps, carry a combined BPC-157/TB-500 blend specifically because researchers commonly investigate the two compounds together in recovery-focused study designs, treating them as mechanistically complementary rather than redundant.
Handling & sourcing notes
Like most research peptides, BPC-157 is typically supplied as a lyophilized powder requiring reconstitution before use in a research protocol, and is sensitive to heat, light, and freeze-thaw cycling once in solution. Purity verification matters significantly for reproducibility in comparative studies — see our methodology page for how we evaluate the sourcing information behind compounds listed in this encyclopedia, and consult Peptide Sift's COA guide for how to interpret a supplier's purity documentation.
Summary
- BPC-157 is a 15-amino-acid synthetic peptide derived from a gastric-protective protein fragment.
- Its research literature spans gastrointestinal protection and broad tissue-repair contexts, including tendon, ligament, and muscle injury models.
- Proposed mechanisms center on angiogenesis and growth-factor pathway modulation.
- The published evidence base is overwhelmingly animal-model research rather than large human trials.
- It is commonly studied alongside TB-500 and sold in combined-blend form by some suppliers.